-
Je něco špatně v tomto záznamu ?
The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
D. Vejrazkova, M. Vankova, J. Vcelak, H. Krejci, K. Anderlova, A. Tura, G. Pacini, A. Sumova, M. Sladek, B. Bendlova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- C-peptid MeSH
- diabetes mellitus 2. typu * epidemiologie genetika MeSH
- glukagon MeSH
- glukosa MeSH
- inzulin MeSH
- inzulinová rezistence * genetika MeSH
- kinetika MeSH
- krevní glukóza MeSH
- lidé MeSH
- porucha glukózové tolerance * epidemiologie genetika MeSH
- prediabetes * MeSH
- receptor melatoninový MT2 * genetika MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Background: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. Results: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. Conclusion: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals.
Department of Molecular Endocrinology Institute of Endocrinology Prague Czechia
Metabolic Unit Institute of Neuroscience National Research Council Padova Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018054
- 003
- CZ-PrNML
- 005
- 20220804134527.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2022.868364 $2 doi
- 035 __
- $a (PubMed)35733780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vejrazkova, Daniela $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
- 245 14
- $a The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics / $c D. Vejrazkova, M. Vankova, J. Vcelak, H. Krejci, K. Anderlova, A. Tura, G. Pacini, A. Sumova, M. Sladek, B. Bendlova
- 520 9_
- $a Background: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. Results: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. Conclusion: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals.
- 650 _2
- $a krevní glukóza $7 D001786
- 650 _2
- $a C-peptid $7 D002096
- 650 12
- $a diabetes mellitus 2. typu $x epidemiologie $x genetika $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glukagon $7 D005934
- 650 _2
- $a glukosa $7 D005947
- 650 12
- $a porucha glukózové tolerance $x epidemiologie $x genetika $7 D018149
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $7 D007328
- 650 12
- $a inzulinová rezistence $x genetika $7 D007333
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a prediabetes $7 D011236
- 650 12
- $a receptor melatoninový MT2 $x genetika $7 D044123
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vankova, Marketa $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
- 700 1_
- $a Vcelak, Josef $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
- 700 1_
- $a Krejci, Hana $u Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Anderlova, Katerina $u Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Tura, Andrea $u Metabolic Unit, Institute of Neuroscience, National Research Council, Padova, Italy
- 700 1_
- $a Pacini, Giovanni $u Metabolic Unit, Institute of Neuroscience, National Research Council, Padova, Italy
- 700 1_
- $a Sumova, Alena $u Laboratory of Biological Rhythms, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Sladek, Martin $u Laboratory of Biological Rhythms, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Bendlova, Bela $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 13, č. - (2022), s. 868364
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35733780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134521 $b ABA008
- 999 __
- $a ok $b bmc $g 1821899 $s 1169297
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 13 $c - $d 868364 $e 20220606 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
- LZP __
- $a Pubmed-20220720